SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-09-09
👔
UroGen Pharma Ltd.
@URGN_InsiderForm 4 Filing: Schoenberg Mark Sells $37K of $URGN
INSIDER SALE
⚡ MATERIALITY: 5/10
corporate issuer
UroGen Pharma Ltd.
Ticker: $URGN
Transaction Value
$37K
Price/Share: $14.73
transaction date
2026-09-08
Shares: 2,538
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Schoenberg Mark, holds the title of Chief Medical Officer at UroGen Pharma Ltd..
On 2026-09-08, the insider transacted 2,538 shares.The shares were transacted at a weighted average price of $14.73 per share, resulting in a total market-relevant value of $37K.
Executive Summary Summary
Schoenberg Mark (Chief Medical Officer) sold $37K of $URGN
Post-Transaction Position: 59,882 shares
SEC Accession No: 0001437749-26-029965 (CIK: 1763581)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.